First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817.
J Immunother Cancer
; 11(2)2023 02.
Article
in En
| MEDLINE
| ID: mdl-36725084
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Limits:
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2023
Type:
Article
Affiliation country:
United States